용해도, 안정성, 투여경로 등을 고려해 선도화합물을 위한 적절한 약물 제형을 개발한다.
화학 원료를 구입해야하는 경우 요청 정보를 제출하여최신견적을받으십시오.
(1RS)-2-(4''-methoxy-4'-phenoxybenzenesulfonyl)-1,2,3,4-tetrahydro-norarmano-1-carboxylic acid
C18H19NOS2
4-nitro-3-(3-bromophenylamino)pyridine N-oxide
N-(3-chlorobenzyl)-N-methylpiperidin-4-amine
methyl 3-(4-((2-chloropyridin-4-yl)ethynyl)phenyl)propanoate
2’-(4-nitrophenoxycarbonyl)paclitaxel
(2R)-2-bromo-4-methylpentanoic acid t-butyl ester
4-BroMo-5,7-diMethyl-2,3-dihydro-1H-inden-1-one
methyl 1-(4-chlorobenzyl)-1H-pyrrole-2-carboxylate
C23H17N5O
N,N'-(6H,12H-5,11-methanodibenzo[b,f][1,5]diazocine-2,8-diyldi-2,1-ethanediyl)-bis[N-(2-methoxycarbonylethyl)phenethylamine]
ethyl 5-(4-(4-fluorobenzamido)phenyl)isoxazole-3-carboxylate
HCl
N-[4-(imidazo[1,2-b]pyridazin-6-yloxy)phenyl]-N'-phenylurea
2-(acetyloxy)-N,N-dimethyl-N-[(trimethylsilyl)methyl]ethanaminium iodide
콜린
N1-(7-chloroquinolin-4-yl)-N2-{2-[(dimethylamino)methyl]benzyl}ethan-1,2-diamine
4,6-디클로로-1-메틸-1H-피라졸로[3,4-B]피리딘
요소
Propanedioic acid, methyl-, monoethyl ester, potassium salt